Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Exchange Rate Effect (2016 - 2025)

Cartesian Therapeutics (RNAC) has disclosed Exchange Rate Effect for 11 consecutive years, with $11000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Exchange Rate Effect rose 173.33% to $11000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $45000.0, a 314.29% increase, with the full-year FY2025 number at $45000.0, up 314.29% from a year prior.
  • Exchange Rate Effect was $11000.0 for Q4 2025 at Cartesian Therapeutics, up from -$10000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $115000.0 in Q2 2022 to a low of -$45000.0 in Q4 2022.
  • A 5-year average of -$600.0 and a median of -$6500.0 in 2021 define the central range for Exchange Rate Effect.
  • Peak YoY movement for Exchange Rate Effect: crashed 650.0% in 2022, then surged 740.0% in 2025.
  • Cartesian Therapeutics' Exchange Rate Effect stood at -$6000.0 in 2021, then plummeted by 650.0% to -$45000.0 in 2022, then surged by 135.56% to $16000.0 in 2023, then crashed by 193.75% to -$15000.0 in 2024, then surged by 173.33% to $11000.0 in 2025.
  • Per Business Quant, the three most recent readings for RNAC's Exchange Rate Effect are $11000.0 (Q4 2025), -$10000.0 (Q3 2025), and $12000.0 (Q2 2025).